2KK-30893-43897
3 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 406 / KY
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Moderna
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
- 2021-03-05
- 2021-03-06
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-24
-
2021-03-30
Dose 2 — Moderna
-
2021-03-30
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, DiarrheaAdult check-in
- 2021-04-02
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-22
- 2021-09-30
-
2021-12-02
Dose 3 — Moderna
-
2022-06-02
Survey response — 6 months, dose 3MedDRA: Antibody test positive, Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: Excessive tiredness. Now testing positive for antibodies.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Survey response — 12 months, dose 3MedDRA: COVID-19, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cold and covidMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-03-30 | Moderna | |
| 3 | 2021-12-02 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-02 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: Excessive tiredness. Now testing positive for antibodies.
Release 12 — 12 months, dose 3
Symptoms: Cold and covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Antibody test positive | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release